Pembrolizumab May Be Preferable to Chemo in Certain Patients
NEW YORK (Reuters Health) – Pembrolizumab may have an edge on chemotherapy for microsatellite instability-high (MSI-H) advanced gastric or gastroesophageal-junction […]
NEW YORK (Reuters Health) – Pembrolizumab may have an edge on chemotherapy for microsatellite instability-high (MSI-H) advanced gastric or gastroesophageal-junction […] Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. COVID-19 vaccine clinical trials involving children […] A digitally supported psychological reasoning intervention known as SlowMo helps patients with persistent paranoia “slow down” their thinking to curb […] Cardiovascular disease was the leading cause of death among the over 16,000 patients with type 2 diabetes (T2DM) who were […] BEIJING (Reuters) – China’s CanSino Biologics Inc said the efficacy rate for its single-dose COVID-19 vaccine may fall over time […] Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. Could a decades-old antidepressant be a […] Patient with suspected large-vessel occlusion stroke who were taken directly to the angiography suite, bypassing the emergency department, received endovascular […]clinical research
Pembrolizumab May Be Preferable to Chemo in Certain Patients
Children and COVID-19 Vaccine Trials: What to Consider
‘SlowMo’ Therapy Offers ‘Freedom and Peace’ From Paranoia
CVD Remains Leading Cause of Death in Type 2 Diabetes
CanSinoBIO Says COVID-19 Shot May Be Less Effective Over Time, Booster Shot Promising
Scientists Seek COVID Treatment Answers in Cheap, Older Drugs
Direct Transfer to Angio Improves Outcome in Large-Vessel Stroke
Copyright © 2024